1. Home
  2. CBAN vs EOLS Comparison

CBAN vs EOLS Comparison

Compare CBAN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$20.08

Market Cap

423.6M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.53

Market Cap

454.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
EOLS
Founded
1975
2012
Country
United States
United States
Employees
506
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
423.6M
454.4M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
CBAN
EOLS
Price
$20.08
$6.53
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
369.5K
766.3K
Earning Date
04-22-2026
05-04-2026
Dividend Yield
2.44%
N/A
EPS Growth
16.91
1.23
EPS
0.39
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$35.41
$13.27
Revenue Next Year
$4.84
$17.62
P/E Ratio
$51.33
N/A
Revenue Growth
N/A
11.61
52 Week Low
$15.80
$3.86
52 Week High
$21.61
$10.20

Technical Indicators

Market Signals
Indicator
CBAN
EOLS
Relative Strength Index (RSI) 47.84 45.06
Support Level $19.20 $6.44
Resistance Level $20.40 $6.95
Average True Range (ATR) 0.51 0.32
MACD -0.09 -0.06
Stochastic Oscillator 26.98 13.59

Price Performance

Historical Comparison
CBAN
EOLS

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: